|83.36||+4.36 / +5.52%|
As of 3:59pm ET
|83.50||+0.14 / +0.17%|
The 6 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 106.50, with a high estimate of 125.00 and a low estimate of 77.00. The median estimate represents a +27.76% increase from the last price of 83.36.
The current consensus among 7 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.